Characterization and Causative Factors of Negative Dysphotopsia (NDys)

January 7, 2020 updated by: Prim. Prof. Dr. Oliver Findl, MBA, Vienna Institute for Research in Ocular Surgery

Defining and Quantifying Negative Dysphotopsia Characterization and Causative Factors of Negative Dysphotopsia

The present study is designed as an exploratory study, seeking to investigate the correlation of patient complaints to subjective or objective measurement methods. Better understanding of causative factors of negative dysphotopsia will improve detection and maybe prediction of this optical phenomenon.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Oliver Findl, MD, Prof.
  • Phone Number: 004319102157564
  • Email: office@viros.at

Study Locations

      • Vienna, Austria, A-1140
        • Recruiting
        • Hanusch-Krankenhaus
        • Contact:
          • Oliver Findl, MD, MBA
          • Phone Number: +431 910 21 84611
          • Email: oliver@findl.at
        • Principal Investigator:
          • Oliver Findl, MD, MBA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

10 patients after cataract extraction, suffering from negative dysphotopsia

Description

Inclusion Criteria:

  • Pseudophakic
  • Recurrently and persistently reporting about negative dysphotopsia
  • Age 21 and older
  • written informed consent prior to entering the study

Exclusion Criteria:

  • Relevant ophthalmic diseases such as: glaucoma, (previous) traumatic cataract, corneal scars, age-related macular degeneration and other pathologies resulting in visual field defects
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of factors or a combination thereof that may cause negative dysphotopsia
Time Frame: 2 hours
Biometry, Anamnesis, visual field, psychological questionnaires, wavefront aberrometry will be used to analyse if a factor causative for negative dysphotopsia can be detected
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Method to standardize characterization of negative dysphotopsia
Time Frame: 20 minutes
New approaches like Goldmann visual field are used to try to picture negative dysphotopsias and patients will also be asked to draw the "dark shadows"
20 minutes
Correlation between eye biometry, patient complaints and psychophysics
Time Frame: 30 minutes
Eye biometry will be measured using IOL Master 700, patient complaints will be asked during an patient-doctor interview, and psychophysics will be assessed using a psychological questionnaire
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (ANTICIPATED)

December 1, 2020

Study Completion (ANTICIPATED)

May 1, 2021

Study Registration Dates

First Submitted

April 11, 2017

First Submitted That Met QC Criteria

January 7, 2020

First Posted (ACTUAL)

January 13, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 13, 2020

Last Update Submitted That Met QC Criteria

January 7, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NDys

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pseudoaphakia

3
Subscribe